MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 114 filers reported holding MAXCYTE INC in Q1 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13 | -7.1% | 3,303 | 0.0% | 0.00% | – |
| Q1 2024 | $14 | -64.1% | 3,303 | -60.3% | 0.00% | – |
| Q4 2023 | $39 | +34.5% | 8,312 | -10.6% | 0.00% | – |
| Q3 2023 | $29 | -32.6% | 9,295 | 0.0% | 0.00% | – |
| Q2 2023 | $43 | -8.5% | 9,295 | -1.5% | 0.00% | – |
| Q1 2023 | $47 | -24.2% | 9,436 | -17.1% | 0.00% | -100.0% |
| Q4 2022 | $62 | -99.9% | 11,387 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $74,000 | +37.0% | 11,387 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $54,000 | -44.3% | 11,387 | -18.2% | 0.00% | 0.0% |
| Q1 2022 | $97,000 | -68.3% | 13,922 | -53.7% | 0.00% | 0.0% |
| Q4 2021 | $306,000 | – | 30,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $20,963,000 | 8.46% |
| NORTH RUN CAPITAL, LP | 556,960 | $3,620,000 | 7.35% |
| Vitruvian Partners LLP | 5,043,356 | $32,782,000 | 5.85% |
| Casdin Capital, LLC | 10,735,786 | $69,783,000 | 4.58% |
| RIVER GLOBAL INVESTORS LLP | 1,867,113 | $11,880,000 | 2.28% |
| APIS CAPITAL ADVISORS, LLC | 200,000 | $1,300,000 | 1.95% |
| Pier Capital, LLC | 1,262,654 | $8,207,000 | 1.41% |
| Montanaro Asset Management Ltd | 929,000 | $6,009,000 | 0.92% |
| First Light Asset Management, LLC | 1,362,543 | $8,857,000 | 0.90% |
| Grandeur Peak Global Advisors, LLC | 1,206,013 | $7,839,000 | 0.48% |